Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Advanced Melanoma: Vaccine Shows Therapeutic Promise
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.
generic viagra online
Pediatric Carbon Monoxide Poisoning Linked To Video Games After Hurricane Ike
Hours after Hurricane Ike roared ashore in Texas, more than two million homes were without power, which left some scrambling to preserve food and others looking for ways to entertain children, a move that proved to be, in some instances, poisonous. Researchers at The University of Texas Health Science Center at Houston found that 75 percent of children treated for carbon monoxide poisoning caused by gasoline-powered electrical generators were playing video games
News of the day
Fertility Prediction Kit Ovu-Trac(R) By OvumOptics Harnesses The Testing Power Of Saliva Testing
Saliva sample testing is fast becoming the diagnostic data collector of choice in a variety of medical testing. Over the past two years, American scientists are turning more to the accuracy of results in saliva sample tests, more than traditional blood and urine tests. Ovu-Trac® is at the leading edge of this scientific knowledge with its ovulation test and predictor kit. These fertility test kits can help women who are trying to conceive a child determine when they are ovulating.
Medical Devices

Stanford's Kuldev Singh, MD Elected To Chair The Glaucoma Research Foundation

Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine, was elected to Chair the Board of the Glaucoma Research Foundation at the Board of Directors Annual Meeting held April 29. The Glaucoma Research Foundation (GRF) is America"s oldest national institution dedicated solely to preventing vision loss from glaucoma. Dr. Singh received his MD and MPH degrees from the Johns Hopkins University School of Medicine. He has received Senior Achievement and Secretariat awards from the American Academy of Ophthalmology and the Franklin G. Ebaugh Award from Stanford University where he has served on the faculty since 1992. Dr. Singh also currently serves on the Board of Directors for the American Glaucoma Society and is Executive Vice President of the World Glaucoma Association. Dr. Singh joined the GRF Board of Directors in April 2007. He is Chairman of the Patient Education Committee and the GRF Council, a national leadership group of glaucoma specialists. Effective July 1, 2009, Dr. Singh will succeed Ms. Deirdre Porter of the San Francisco firm Wentworth, Hauser, and Violich, Inc. who has served the past three years as Board Chair for the Foundation. "Kuldev has already brought many inventive ideas to GRF during his time serving on the Board of Directors, and we look forward to the leadership that his broad knowledge and experience in the field of glaucoma will bring to the Foundation," said Thomas M. Brunner, GRF President and CEO. The Glaucoma Research Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009